Analystreport

Trillium Therapeutics Inc. (NASDAQ: TRIL) had its price target raised by analysts at Craig Hallum from $15.00 to $21.00.

Trillium Therapeutics Inc. - Common Shares  (TRIL) 
Last trillium therapeutics inc. - common shares earnings: 5/13 07:00 am Check Earnings Report